Eugia Pharma Receives USFDA Approval for Milrinone Lactate in 5% Dextrose Injection, 20 mg/100 mL and 40 mg/200 mL
Published: September 03, 2020
Eugia Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Milrinone Lactate in 5% Dextrose Injection, 20 mg/100 mL (200 mcg (0.2 mg)/mL) and 40 mg/200 mL (200 mcg (0.2 mg)/mL).
Refer to package insert for full prescribing information.